Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance

被引:23
作者
Chun, Kyung-Soo [1 ]
Joo, Sang Hoon [2 ]
机构
[1] Keimyung Univ, Coll Pharm, Daegu 42601, South Korea
[2] Daegu Catholic Univ, Dept Pharm, Gyongsan 38430, South Korea
关键词
Reactive oxygen species; Cancer; Resistance; 5-Fluorouracil; HUMAN COLORECTAL-CANCER; CELL-CYCLE ARREST; LIVER-CANCER; CLINICAL-SIGNIFICANCE; OXIDATIVE STRESS; AMINOPEPTIDASE-N; ANTITUMOR-ACTIVITY; INDUCED APOPTOSIS; CARCINOMA CELLS; NADPH OXIDASE;
D O I
10.4062/biomolther.2022.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Fluorouracil (5-FU) remains to be an important chemotherapeutic drug for treating several cancers when targeted therapy is unavailable. Chemoresistance limits the clinical utility of 5-FU, and new strategies are required to overcome the resistance. Reactive oxygen species (ROS) and antioxidants are balanced differently in both normal and cancer cells. Modulating ROS can be one method of overcoming 5-FU resistance. This review summarizes selected compounds and endogenous cellular targets modulating ROS generation to overcome 5-FU resistance.
引用
收藏
页码:479 / 489
页数:11
相关论文
共 110 条
[1]  
Afrin S., 2018, INHIBITORY EFFECT MA
[2]   Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability [J].
Afrin, Sadia ;
Giampieri, Francesca ;
Forbes-Hernandez, Tamara Y. ;
Gasparrini, Massimiliano ;
Amici, Adolfo ;
Cianciosi, Danila ;
Quiles, Jose L. ;
Battino, Maurizio .
FREE RADICAL BIOLOGY AND MEDICINE, 2018, 126 :41-54
[3]   Natural gypenosides: targeting cancer through different molecular pathways [J].
Ahmad, Bashir ;
Khan, Suliman ;
Nabi, Ghulam ;
Gamallat, Yaser ;
Su, Pengyu ;
Jamalat, Yazeed ;
Duan, Pengfei ;
Yao, Lunguang .
CANCER MANAGEMENT AND RESEARCH, 2019, 11 :2287-2297
[4]   Antioxidant and radical scavenging properties of curcumin [J].
Ak, Tuba ;
Gulcin, Ilhami .
CHEMICO-BIOLOGICAL INTERACTIONS, 2008, 174 (01) :27-37
[5]   Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells [J].
Akhdar, Hanane ;
Loyer, Pascal ;
Rauch, Claudine ;
Corlu, Anne ;
Guillouzo, Andre ;
Morel, Fabrice .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) :2219-2227
[6]  
Alnuqaydan AM, 2020, AM J CANCER RES, V10, P799
[7]   Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters [J].
Bai, Xupeng ;
Chen, Yibei ;
Hou, Xiangyu ;
Huang, Min ;
Jin, Jing .
DRUG METABOLISM REVIEWS, 2016, 48 (04) :541-567
[8]   Anticancer activities and mechanism of action of the labdane diterpene coronarin D [J].
Bailly, Christian .
PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (06)
[9]   5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes [J].
Blondy, Sabrina ;
David, Valentin ;
Verdier, Mireille ;
Mathonnet, Muriel ;
Perraud, Aurelie ;
Christou, Niki .
CANCER SCIENCE, 2020, 111 (09) :3142-3154
[10]   INITIAL THERAPY OF PATIENTS WITH WILSONS-DISEASE WITH TETRATHIOMOLYBDATE [J].
BREWER, GJ ;
DICK, RD ;
YUZBASIYANGURKIN, V ;
TANKANOW, R ;
YOUNG, AB ;
KLUIN, KJ .
ARCHIVES OF NEUROLOGY, 1991, 48 (01) :42-47